LatAm / Big Indian Investment; Argentina's COVID-19 Woes; Cannabis ‘Green Rush’ in Mexico
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…
Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark,…
The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…
A roundup of the latest from the Middle East & Africa region, including Turkey’s debt to US pharma; deals…
The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues…
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all…
The USA is now Switzerland’s biggest export market and in 2019 Switzerland exported more to the US than to…
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if…
In the aftermath of the fiery first presidential debate between incumbent Donald Trump and Democratic Party rival…